.Attributes Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for incorporation of people with MASLD and measurement of liver end results in cardio-- kidney-- metabolic trials, when data recommend mechanistically possible benefits and also scientific safety and security-- as well as describes factors to consider for test design and also regulative commendation.